Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2012-06-15 Declaration of Voting R…
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 11, 2012. The content focuses on the submission of matters to a vote of security holders at the Annual Meeting, including election of directors, ratification of the independent auditor, and approval of an increase in shares under the stock incentive plan. This corresponds to an official announcement of voting results from a shareholder meeting. The document is relatively short (3676 characters) and contains detailed vote counts, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not an Annual Report, Audit Report, or Management Report, nor is it a proxy solicitation or presentation. Therefore, the correct classification is DVA with high confidence.
2012-06-15 English
Major Shareholding Notification 2012
Major Shareholding Notification
2012-06-08 English
BENEFICIAL OWNERSHIP REPORT
Major Shareholding Notification
2012-05-22 English
PROSPECTUS SUPPLEMENT - RULE 424(B)(5)
Regulatory Filings Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a common stock offering by Novavax, Inc. It details the offering of 10,000,000 shares, use of proceeds, dilution, plan of distribution, and risk factors. It references SEC filings such as the Annual Report on Form 10-K and Quarterly Report on Form 10-Q but is itself a disclosure document for a securities offering, not a financial report or earnings release. The document is a regulatory filing related to capital raising but is not a direct capital/financing update announcement or earnings release. It fits best under the category of Regulatory Filings (RNS) as a general SEC filing that does not neatly fit into other categories like Capital/Financing Update or Earnings Release. The document length and content confirm it is not a brief announcement or a report publication announcement.
2012-05-21 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a financing transaction where the company agreed to sell 10,000,000 shares of common stock to affiliates of RA Capital Management, LLC. It includes details about the offering price, proceeds, and related legal opinions. There is no detailed financial report or earnings data, but rather an update on a capital raising event. This fits the definition of a Capital/Financing Update (CAP). The document length is 4058 characters, which is consistent with a typical 8-K filing announcing a financing event rather than a full report. Therefore, the correct classification is CAP with high confidence.
2012-05-21 English
FORM 4 SUBMISSION
Director's Dealing
2012-05-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.